Infection prevention plan to decrease surgical site infections in bariatric surgery patients.
Bariatric surgery
Complications of bariatric surgery
Surgical drain
Surgical site infection
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
03
02
2021
accepted:
04
05
2021
pubmed:
13
5
2021
medline:
21
4
2022
entrez:
12
5
2021
Statut:
ppublish
Résumé
Surgical site infections (SSI) are one of the most common complications of bariatric surgery. The Metabolic and Bariatric Surgery Accreditation and Quality Improvement (QI) Program (MBSAQIP) allows accredited programs to develop processes for quality improvement based on data collection. The objective of this study was to decrease SSI rates in patients undergoing bariatric surgery at an accredited MBSAQIP center. Using the MBSAQIP semiannual report, SSI rates were retrospectively reviewed. Baseline SSI rates were collected from 01/01/2014-12/31/2015. On 01/01/2016, the first infection prevention protocol (IPP-1) was created that included 4% chlorhexidine gluconate (CHG) showers, CHG wipes immediately prior to surgery, and routine cultures of SSIs. An updated IPP (IPP-2) was implemented on 09/01/2016, which discontinued routine surgical drain placement and broadened antibiotic coverage for penicillin allergic patients. During baseline data collection, SSI rates were 5.1%. After the implementation of IPP-1, SSI rates trended down to 2.5%. After implementation of IPP-2, SSI rates decreased significantly to 1.5%, a 66% relative risk reduction in SSIs from baseline. On multivariate regression analysis, the perioperative factors associated with an increased risk for SSIs included diabetes mellitus, intraoperative surgical drain placement, the number of hypertension medications prior to bariatric surgery, and an open approach. Our study demonstrates that the implementation of a specific protocol for reducing SSIs is safe and feasible in patients undergoing bariatric surgery. We also identified that the success of the IPP is likely centered on the elimination of routine drain placement during primary bariatric procedures.
Sections du résumé
BACKGROUND
Surgical site infections (SSI) are one of the most common complications of bariatric surgery. The Metabolic and Bariatric Surgery Accreditation and Quality Improvement (QI) Program (MBSAQIP) allows accredited programs to develop processes for quality improvement based on data collection. The objective of this study was to decrease SSI rates in patients undergoing bariatric surgery at an accredited MBSAQIP center.
METHODS
Using the MBSAQIP semiannual report, SSI rates were retrospectively reviewed. Baseline SSI rates were collected from 01/01/2014-12/31/2015. On 01/01/2016, the first infection prevention protocol (IPP-1) was created that included 4% chlorhexidine gluconate (CHG) showers, CHG wipes immediately prior to surgery, and routine cultures of SSIs. An updated IPP (IPP-2) was implemented on 09/01/2016, which discontinued routine surgical drain placement and broadened antibiotic coverage for penicillin allergic patients.
RESULTS
During baseline data collection, SSI rates were 5.1%. After the implementation of IPP-1, SSI rates trended down to 2.5%. After implementation of IPP-2, SSI rates decreased significantly to 1.5%, a 66% relative risk reduction in SSIs from baseline. On multivariate regression analysis, the perioperative factors associated with an increased risk for SSIs included diabetes mellitus, intraoperative surgical drain placement, the number of hypertension medications prior to bariatric surgery, and an open approach.
CONCLUSIONS
Our study demonstrates that the implementation of a specific protocol for reducing SSIs is safe and feasible in patients undergoing bariatric surgery. We also identified that the success of the IPP is likely centered on the elimination of routine drain placement during primary bariatric procedures.
Identifiants
pubmed: 33978849
doi: 10.1007/s00464-021-08548-1
pii: 10.1007/s00464-021-08548-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2582-2590Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Shepard J, Ward W, Milstone A, Carlson T, Frederick J, Hadhazy E et al (2013) Financial impact of surgical site infections on hospitals: the hospital management perspective. JAMA Surg 148:907–914
doi: 10.1001/jamasurg.2013.2246
Wick EC, Shore AD, Hirose K, Ibrahim AM, Gearhart SL, Efron J et al (2011) Readmission rates and cost following colorectal surgery. Dis Colon Rectum 54:1475–1479
doi: 10.1097/DCR.0b013e31822ff8f0
Mahmoud NN, Turpin RS, Yang G, Saunders WB (2009) Impact of surgical site infections on length of stay and costs in selected colorectal procedures. Surg Infect (Larchmt) 10:539–544
doi: 10.1089/sur.2009.006
Chopra T, Marchaim D, Lynch Y, Kosmidis C, Zhao JJ, Dhar S et al (2012) Epidemiology and outcomes associated with surgical site infection following bariatric surgery. Am J Infect Control 40:815–819
doi: 10.1016/j.ajic.2011.10.015
Broex EC, van Asselt AD, Bruggeman CA, van Tiel FH (2009) Surgical site infections: how high are the costs? J Hosp Infect 72:193–201
doi: 10.1016/j.jhin.2009.03.020
Christou NV, Jarand J, Sylvestre JL, McLean AP (2004) Analysis of the incidence and risk factors for wound infections in open bariatric surgery. Obes Surg 14:16–22
doi: 10.1381/096089204772787239
Topaloglu S, Avsar FM, Ozel H, Babacan M, Berkem H, Yildiz Y et al (2005) Comparison of bariatric and non-bariatric elective operations in morbidly obese patients on the basis of wound infection. Obes Surg 15:1271–1276
doi: 10.1381/096089205774512465
Wahl TS, Patel FC, Goss LE, Chu DI, Grams J, Morris MS (2018) The obese colorectal surgery patient: surgical site infection and outcomes. Dis Colon Rectum 61:938–945
doi: 10.1097/DCR.0000000000001085
Ohman KA, Wan L, Guthrie T, Johnston B, Leinicke JA, Glasgow SC et al (2017) Combination of oral antibiotics and mechanical bowel preparation reduces surgical site infection in colorectal surgery. J Am Coll Surg 225:465–471
doi: 10.1016/j.jamcollsurg.2017.06.011
Ibrahim AM, Ghaferi AA, Thumma JR, Dimick JB (2017) Variation in outcomes at bariatric surgery centers of excellence. JAMA Surg 152:629–636
doi: 10.1001/jamasurg.2017.0542
Barnes-Jewish Hopsital Department of Clinical Microbiology. Antibiogram January-December 2012.
Freeman JT, Anderson DJ, Hartwig MG, Sexton DJ (2011) Surgical site infections following bariatric surgery in community hospitals: a weighty concern? Obes Surg 21:836–840
doi: 10.1007/s11695-010-0105-3
Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP). Operations manual. MBSAQIP variables and definitions 2021.
Tanner J, Padley W, Assadian O, Leaper D, Kiernan M, Edmiston C (2015) Do surgical care bundles reduce the risk of surgical site infections in patients undergoing colorectal surgery? A systematic review and cohort meta-analysis of 8,515 patients. Surgery 158:66–77
doi: 10.1016/j.surg.2015.03.009
Koek MBG, Hopmans TEM, Soetens LC, Wille JC, Geerlings SE, Vos MC et al (2017) Adhering to a national surgical care bundle reduces the risk of surgical site infections. PLoS One 12:e0184200
doi: 10.1371/journal.pone.0184200
Ferraz AAB, Vasconcelos CFM, Santa-Cruz F, Aquino MAR, Buenos-Aires VG, Siqueira LT (2019) Surgical site infection in bariatric surgery: results of a care bundle. Rev Col Bras Cir 46:e2252
doi: 10.1590/0100-6991e-20192252
Doumouras AG, Maeda A, Jackson TD (2017) The role of routine abdominal drainage after bariatric surgery: a metabolic and bariatric surgery accreditation and quality improvement program study. Surg Obes Relat Dis 13:1997–2003
doi: 10.1016/j.soard.2017.08.019
Kavuturu S, Rogers AM, Haluck RS (2012) Routine drain placement in Roux-en-Y gastric bypass: an expanded retrospective comparative study of 755 patients and review of the literature. Obes Surg 22:177–181
doi: 10.1007/s11695-011-0560-5
Gundogan E, Kayaalp C, Aktas A, Saglam K, Sansal M, Gokler C et al (2018) Influence of drain placement on postoperative pain following laparoscopic Roux-en-Y gastric bypass for morbid obesity: randomized controlled trial. Obes Surg 28:3499–3504
doi: 10.1007/s11695-018-3374-x
Thorell A, MacCormick AD, Awad S, Reynolds N, Roulin D, Demartines N et al (2016) Guidelines for perioperative care in bariatric surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg 40:2065–2083
doi: 10.1007/s00268-016-3492-3
Salgado W Jr, Cunha Fde Q, dos Santos JS, Nonino-Borges CB, Sankarankutty AK, de Castro e Silva O, Jr, et al (2010) Routine abdominal drains after Roux-en-Y gastric bypass: a prospective evaluation of the inflammatory response. Surg Obes Relat Dis 6:648–52
doi: 10.1016/j.soard.2009.09.017
Clapp B, Lodeiro C, Dodoo C, Coleman G, Sadri B, Wicker E et al (2020) Trends in Drain utilization in bariatric surgery: an analysis of the mbsaqip database 2015–2017. Obes Surg 30:569–579
doi: 10.1007/s11695-019-04215-6
Committee ACI (2009) ASMBS guideline on the prevention and detection of gastrointestinal leak after gastric bypass including the role of imaging and surgical exploration. Surg Obes Relat Dis 5:293–296
doi: 10.1016/j.soard.2009.02.002
Kim J, Azagury D, Eisenberg D, DeMaria E, Campos GM (2015) ASMBS position statement on prevention, detection, and treatment of gastrointestinal leak after gastric bypass and sleeve gastrectomy, including the roles of imaging, surgical exploration, and nonoperative management. Surg Obes Relat Dis 11:739–48
doi: 10.1016/j.soard.2015.05.001
Gray EC, Dawoud F, Janelle M, Hodge M (2020) Drain Placement during bariatric surgery, helpful or harmful? Am Surg 86:971–975
doi: 10.1177/0003134820942168
Pettett BJ, Eskildsen SM, Huang KX, Ostrum RF (2019) Despite the safety of preoperative cefazolin for patients with non-anaphylactic penicillin allergy, 20% of practitioners avoid its use. Orthopedics 42:e437–e442
doi: 10.3928/01477447-20190604-03
Romano A, Valluzzi RL, Caruso C, Zaffiro A, Quaratino D, Gaeta F (2020) Tolerability of itcefazolin and ceftibuten in patients wh IgE-mediated aminopenicillin allergy. J Allergy Clin Immunol Pract 8(6):1989–1993
doi: 10.1016/j.jaip.2020.02.025
Huntington C, Gamble J, Blair L, Cox T, Prasad T, Lincourt A et al (2016) Quantification of the effect of diabetes mellitus on ventral hernia repair: results from two national registries. Am Surg 82:661–671
doi: 10.1177/000313481608200822
Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R et al (2016) Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37:88–99
doi: 10.1017/ice.2015.249
Yang J, Zhang X, Liang W (2020) A retrospective analysis of factors affecting surgical site infection in orthopaedic patients. J Int Med Res 48:300060520907776
pubmed: 32281431
Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA (2006) Long-term glycemic control and postoperative infectious complications. Arch Surg 141:375–380
doi: 10.1001/archsurg.141.4.375
Ejaz A, Schmidt C, Johnston FM, Frank SM, Pawlik TM (2017) Risk factors and prediction model for inpatient surgical site infection after major abdominal surgery. J Surg Res 217:153–159
doi: 10.1016/j.jss.2017.05.018